There are no deals set to price in the first week of the new year; however, filing activity will continue from companies targeting 1Q18 IPOs. The IPO market rounded out 2017 at an even 160 IPOs, raising $35.5 billion in total proceeds, nearly double that of 2016...read more
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more
Luther Burbank, a California commercial thrift focused on single and multifamily residential loans, raised $131 million by offering 12.2 million shares at $10.75, within the range of $10.50 to $12.50. Luther Burbank plans to list on the Nasdaq under the symbol...read more
The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more
US IPO Week Ahead: 2018 IPO market kicks off with a quiet week
There are no deals set to price in the first week of the new year; however, filing activity will continue from companies targeting 1Q18 IPOs. The IPO market rounded out 2017 at an even 160 IPOs, raising $35.5 billion in total proceeds, nearly double that of 2016...read more
US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more
Luther Burbank prices IPO at $10.75, within the range
Luther Burbank, a California commercial thrift focused on single and multifamily residential loans, raised $131 million by offering 12.2 million shares at $10.75, within the range of $10.50 to $12.50. Luther Burbank plans to list on the Nasdaq under the symbol...read more
US IPO Week Ahead: Two big biotechs lead 6-IPO week
The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more